Trial Recruitment
AGITG Trial news: The AGITG currently has 12 studies open to recruitment and 13 studies in... Read More
A recap of the AGITG Preceptorship in Biliary Tract Cancer and Hepatocellular Carcinoma
Thank you to Dr Deborah Zhou and Dr Joanna Lee for their contributions to this article. Another successful AGITG... Read More
Changes to the AGITG Board – thank you and welcome
With recent changes to the AGITG Board of Directors, the team would like to express our heartfelt gratitude... Read More
Highlights from ASCO 2023: A focus on accessible, patient-centred care
The theme at the 2023 ASCO Annual Meeting was ‘Partnering with Patients: The Cornerstone of Cancer Care and... Read More
The Health Studies Australian National Data Asset (HeSANDA)
The AGITG is excited to be involved in a national project, the Australian Research Data Commons (ARDC), and... Read More
Welcome to our new Scientific Advisory Committee members
This past few weeks, the AGITG Scientific Advisory Committee (SAC) has undergone a renewal process. Providing opportunities for... Read More
The 2023 Late-Stage Colorectal Cancer Idea Generation Workshop
This year’s Idea Generation Workshop was held on Friday 19 May, facilitated by A/Prof Cherry Koh and... Read More
Thank you to GI cancer research pioneers
This past few weeks, the AGITG Scientific Advisory Committee (SAC) has undergone a renewal process. Providing opportunities for... Read More
From idea to innovation: Dr Fiona Chionh on the VADER trial
Dr Fiona Chionh is a medical oncologist at Austin Hospital as well as a clinician-scientist at the Olivia... Read More
Our highlights from ASCO GI 2023
INTEGRATE IIa results presented Results for INTEGRATE IIa, a phase III AGITG trial, were presented at the 2023... Read More
INTEGRATE IIa results presented at ASCO GI 2023
NEWS FROM ASCO GI “International clinical trial demonstrates improved survival with new treatment for patients with advanced gastro-oesophageal cancer” Results... Read More
The 2022 John Zalcberg OAM Award presented to a trailblazing clinician-researcher
We are excited to announce that the 2022 John Zalcberg OAM Award for Excellence in AGITG Research... Read More
Congratulations to winners of the 2022 AGITG awards at the ASM
At the 24th AGITG Annual Scientific Meeting, held in Melbourne between 14-17 November 2022, the AGITG presented awards... Read More
Member Spotlight: Professor Rob Ramsay
Professor Rob Ramsay is Head of the Differentiation and Transcription Laboratory at Peter MacCallum Cancer Centre, Melbourne. He... Read More
Welcoming Sandra Bahamad to the team
Sandra recently joined the AGITG and GI Cancer Institute as Clinical Trials Project Manager. HOW DID YOU COME TO... Read More
Community Spotlight: Mental Health Month for clinicians
October is Mental Health Month in Australia, and this month we are shining our community spotlight on mental... Read More
Dr Sarah Hayes on the AGITG Translational Research Program
At the AGITG, we have exciting new developments for our Translational Research Program, which will add cutting-edge value... Read More
Research breakthroughs in stomach and oesophageal cancer
One exciting development has us very hopeful. A novel protein marker known as STING has been found to... Read More
Member Spotlight: Associate Professor Haryana Dhillon
Associate Professor Haryana Dhillon is a behavioural scientist and psycho-oncologist at the University of Sydney, working with people... Read More
August 2022: Research Update
This is August’s research update from the AGITG. MASTERPLAN Study Chairs: Dr Andrew Oar and A/Prof Andrew Kneebone The first patient to achieve a pathological complete response on the MASTERPLAN trial is an outcome worth celebrating! Congratulations to the study team! With this promising result, we encourage members to refer eligible candidates to... Read More